Background illustration for clinical trials search

Paid Clinical Trials Richmond

Discover 561 paid clinical trials in Richmond, Virginia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
FeaturedActive & Responsive

A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

for
Moderately to Severely Active Crohns Disease
Location: Williamsburg VA, Chesapeake VA, Lynchburg VA,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 16 - 70+

Code: NCT06819878

Phase3, Recruiting
Featured

Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis

for
Idiopathic Pulmonary Fibrosis
Location: Richmond VA, Falls Church VA, Philadelphia PA,
Sponsor: AbbVie

Sex: All

Age: 40+

Code: NCT07230288

Phase2, Recruiting
Featured

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

for
Parkinson's Disease
Location: Richmond VA, Charlottesville VA, Washington D.C. DC,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 50 - 70+

Code: NCT07174310

Phase3, Recruiting
Featured

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis,
Location: Richmond VA, Greenbelt MD, Glen Burnie MD, Baltimore MD,
Sponsor: 89bio, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06318169

Phase3, Recruiting
Featured

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

for
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis,
Location: Richmond VA, Greenbelt MD, Glen Burnie MD, Baltimore MD,
Sponsor: 89bio, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06419374

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Featured

A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease

for
Von Willebrand Disease, Type 3
Location: Richmond VA, Lexington KY, Toronto, Montreal,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 0+

Code: NCT06998524

Phase3, Recruiting
FeaturedNew

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

for
Obesity, Overweight
Location: Richmond VA, Newport News VA, Arlington VA, Danville VA,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT07752979

Phase2, Recruiting
Featured

A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

for
Alzheimers Disease
Location: Richmond VA, Greensboro NC, Ridgewood NJ, New York NY,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 50 - 70+

Code: NCT07169578

Phase3, Recruiting
Featured

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

for
Moderately to Severely Active Crohns Disease
Location: Richmond VA, Chevy Chase MD, Baltimore MD,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 16 - 70+

Code: NCT06819891

Phase3, Recruiting
Active & Responsive

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Richmond VA, Charlottesville VA, Baltimore MD,
Sponsor: Bicara Therapeutics

Sex: All

Age: 18+

Code: NCT06788990

Phase2, Phase3, Recruiting
Active & Responsive

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

for
Acute Myeloid Leukemia
Location: Richmond VA, Washington D.C. DC, Wilmington DE,
Sponsor: PedAL BCU, LLC

Sex: All

Age: 0 - 21

Code: NCT05183035

Phase3, Recruiting
Active & Responsive

A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes

for
Diabetes Mellitus, Type 1, Impaired Hypoglycemic Awareness,
Location: Richmond VA, Philadelphia PA, Pittsburgh PA, Toronto,
Sponsor: Vertex Pharmaceuticals Incorporated

Sex: All

Age: 18 - 65

Code: NCT04786262

Phase3, Recruiting
Active & Responsive

A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

for
Anemia, Sickle Cell, Healthy Volunteers
Location: Richmond VA, Fairfax VA, Philadelphia PA, New Haven CT,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06481306

Phase1, Phase2, Recruiting
Active & Responsive

Examining Lateralized Aspects of Motor Control Using Non-invasive Neural Stimulation

for
Motor Adaptation and Generalization, Posterior Parietal Cortex,
Location: Richmond VA
Sponsor: Virginia Commonwealth University

Sex: All

Age: 18 - 40

Code: NCT05947279

Recruiting
Active & Responsive

A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease

for
Huntington Disease
Location: Richmond VA, Washington D.C. DC, Baltimore MD,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 21 - 70

Code: NCT07326709

Phase3, Recruiting
Active & Responsive

Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

for
Relapsing Multiple Sclerosis,
Location: Richmond VA, Charlottesville VA, Philadelphia PA,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 55

Code: NCT04047628

Phase3, Recruiting
Active & Responsive

A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment

for
Primary Biliary Cholangitis
Location: Richmond VA, Chapel Hill NC, Cherry Hill NJ,
Sponsor: Ipsen

Sex: All

Age: 0+

Code: NCT06447168

Recruiting
Active & ResponsiveNew

Safety and Tolerability Study of VVZ-2471 in Healthy Volunteers

for
Healthy Controls
Location: Richmond VA
Sponsor: Virginia Commonwealth University

Sex: All

Age: 18 - 65

Code: NCT07531316

Phase1, Recruiting
Active & Responsive

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

for
Advanced Endometrial Carcinoma, Recurrent Endometrial Carcinoma
Location: Richmond VA, Charlottesville VA, Washington D.C. DC,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT07198074

Phase3, Recruiting
Active & Responsive

Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

for
Metastatic Dedifferentiated Liposarcoma,
Location: Richmond VA, Charlottesville VA, Durham NC,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06422806

Phase3, Recruiting